Samsung’s investment unit is watching medical-based investments based medical device, EXO, in a circle that can climb $ 100 million, Bloomberg reportedDiscuss unknown sources.
The round was led by capital Sands, Bold Capital Capital, the report said, adding that Quit’s chairman Imar Ishrak, joined Quab’s board.
Built in 2015, EXO makes handheld medical imagery devices in artificial intelligence, medical explanation technology such as lung scan or echocardiograms. The device plugs into a smartphone, and medical examiners can scan patients, documents, and sharing exam reports using an app.
The company So far to rise more than $ 320 million In funding from investors including capital management of RA, Blackrock, Sands Capital, Intel, Sony, and air partners. The company is most recently adds a $ 220 million to series C Round of 2021.
EXO also with the Samsung Medon Fo Partner talks., Which makes medical devices for the inpsueound diagnostics and digital X-ray systems, the report says.
Exo, Samsung Capital in Sands, Bold Capital and Health Health not immediately returned requests for commentary.
